|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV033962413 |
| 003 |
DE-627 |
| 005 |
20230625195510.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2014 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/S0378-3782(14)70006-4
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2014012000026.pica
|
| 035 |
|
|
|a (DE-627)ELV033962413
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(14)70006-4
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Zecca, Marco
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Possible alternatives to antimicrobial therapies
|
| 264 |
|
1 |
|c 2014transfer abstract
|
| 300 |
|
|
|a 3
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a The care of immunosuppressed patients has constantly improved over the years, and pharmacologic developments contributed significantly to this success. However, despite these advances, current anti-infectious agents are limited in their efficacy by either weak specificity or side effects, including suppression of bone marrow function. Control of infection will ultimately depend on reconstitution of specific immunity. Thus, adoptive cellular immunotherapy represents an attractive, low-toxicity strategy to restore specific immune surveillance, and prevent/treat potentially life-threatening disease due to pathogens relevant to the immunosuppressed host.
|
| 520 |
|
|
|a The care of immunosuppressed patients has constantly improved over the years, and pharmacologic developments contributed significantly to this success. However, despite these advances, current anti-infectious agents are limited in their efficacy by either weak specificity or side effects, including suppression of bone marrow function. Control of infection will ultimately depend on reconstitution of specific immunity. Thus, adoptive cellular immunotherapy represents an attractive, low-toxicity strategy to restore specific immune surveillance, and prevent/treat potentially life-threatening disease due to pathogens relevant to the immunosuppressed host.
|
| 650 |
|
7 |
|a T cell therapy
|2 Elsevier
|
| 650 |
|
7 |
|a Transplantation
|2 Elsevier
|
| 650 |
|
7 |
|a Fungal infections
|2 Elsevier
|
| 650 |
|
7 |
|a Viral infections
|2 Elsevier
|
| 700 |
1 |
|
|a Maccario, Rita
|4 oth
|
| 700 |
1 |
|
|a Basso, Sabrina
|4 oth
|
| 700 |
1 |
|
|a Comoli, Patrizia
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:90
|g year:2014
|g pages:16-18
|g extent:3
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/S0378-3782(14)70006-4
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 90
|j 2014
|h 16-18
|g 3
|y 90.2014, S16-, (3 S.)
|
| 953 |
|
|
|2 045F
|a 610
|